355013-79-5

Basic information

• Product Name: 4-ChloroMethyl-2-Methoxy-pyridine
• Synonyms: 4-ChloroMethyl-2-Methoxy-pyridine;Pyridine, 4-(chloroMethyl)-2-Methoxy-
• CAS NO: 355013-79-5
• Molecular Formula: C₇H₈ClNO
• Molecular Weight: 157.59752
• Mol File: 355013-79-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 4-ChloroMethyl-2-Methoxy-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ChloroMethyl-2-Methoxy-pyridine(355013-79-5)
• EPA Substance Registry System: 4-ChloroMethyl-2-Methoxy-pyridine(355013-79-5)

Safety Data

• Hazardous Substances Data: 355013-79-5(Hazardous Substances Data)

Usage

General Description

4-ChloroMethyl-2-Methoxy-pyridine, also known as CMMP, is a chemical compound with the molecular formula C7H8ClNO. It is a chlorinated aromatic compound that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. CMMP is a pale yellow to brown liquid with a molecular weight of 157.6 g/mol. It is primarily used as a building block in the production of various pyridine derivatives. Additionally, CMMP has been studied for its potential anti-inflammatory and analgesic properties, making it a valuable compound in the development of new drug candidates. However, it is important to handle CMMP with caution, as it can be harmful if ingested, inhaled, or comes into contact with the skin.

Upstream product

• 105596-63-2 2-methoxy-isonicotinic acid 
• 26156-51-4 methyl 2-methoxyisonicotinate 
• 58481-11-1 methyl 2-chloroisonicotinate 
• 123148-66-3 2-methoxy-4-(hydroxymethyl)-pyridine 

Downstream Products

• 764708-27-2 2-(2-methoxypyridin-4-yl)ethylamine 
• 1395552-82-5 2-(4-bromo-3-fluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 764708-39-6 C₁₈H₁₆BrFN₄O 
• 764708-28-3 2-(4-bromo-2,5-difluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 1395552-89-2 2-(4-chloro-2,5-difluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 1395552-94-9 2-(4-chloro-2,5-difluorophenyl)-6-ethyl-N-[2-(2-methoxypyridin-4-yl)ethyl]pyrimidin-4-amine 
• 764708-29-4 4-(2-{[2-(4-Bromo-2,5-difluorophenyl)-6-methylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 
• 794485-71-5 4-(2-{[2-(4-chloro-2,5-difluorophenyl)-6-methylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 
• 795266-61-4 4-(2-{[2-(4-chloro-2,5-difluorophenyl)-6-ethylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 

Relevant articles and documents

PYRAZOLO[3,4-b]PYRIDINES AND IMIDAZO[1,5-b]PYRIDAZINES AS PDE1 INHIBITORS

The present invention provides compounds of formula (I) that are PDE1 enzyme inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.

QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention is directed to quinoline amide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.